Bilal Arif

Bilal Arif

Executive Vice President, Chief Technical Operations OfficeratSarepta Therapeutics· In proxies 2021–2024

Pay in FY2024-28% from the year before · Sarepta Therapeutics stock +26.1% the same year

Bilal Arif was paid $2.5M in FY2024 (Dec), down 28%. Sarepta Therapeutics stock rose 26.1% that year.

Pay$100 in the stock at the end of FY20 → $71
Pay is from the Summary Compensation Table of each Sarepta Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Sarepta TherapeuticsPublic company · 5 yr
    • Executive Vice President, Chief Technical Operations Officer2021 – Present · 5 yrStock in role -89%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?